The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

StocksMedium•13 February 2026•

1 min read

Amwell Narrows 2025 Losses, Forecasts Cautious 2026 Revenue with Continued EBITDA Gains

3D metallic 'PVH' text with 'CALVIN KLEIN' and 'TOMMY HILFIGER' names. Upward trend line, 'EARNINGS BEAT', 'REVENUE: +14%', and '2026 GUIDANCE' on an orange background.

Amwell (NYSE: AMWL) reported a significant improvement in its 2025 financial performance, sharply reducing its net loss to $95.0 million from $212.6 million in 2024. The company also enhanced its 2025 Adjusted EBITDA, improving it to $(39.9) million from $(134.4) million previously. However, Amwell issued cautious revenue guidance for 2026, forecasting figures between $195 million and $205 million. Conversely, the company projects continued improvement in 2026 Adjusted EBITDA, expecting it to reach a range of $(24) million to $(18) million. Amwell aims to achieve positive cash flow from operations by the fourth quarter of 2026, driven by its strategic shift towards a leaner, more efficient model.